Clinical Trial Update: Tislelizumab Combined With Chemotherapy in the Treatment of Bone Metastases of Unknown Primary [Phase 2]

View source ↗

Summary

Phase 2 trial updating tislelizumab plus chemotherapy for bone metastases of unknown primary; disease specifics not fully defined in the snippet.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastasis
• Cancer of Unknown Primary

Drugs mentioned

• Chemotherapy (chemotherapy)
• Tislelizumab (tislelizumab)

Snippet

Sponsor: Wei Xu | Conditions: Cancer of Unknown Primary, Bone Cancer Metastatic | Phase 2 | Status: UNKNOWN